{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-222720","form_type":"8-K","ticker":"SBC","cik":"0001930313","company_name":"SBC Medical Group Holdings Inc","filed_at":"2026-05-14T10:50:17+00:00","discovered_at":"2026-05-14T10:55:00.392939+00:00","generated_at":"2026-05-14T10:55:09.043695+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"SBC Medical Q1 revenue falls 9% to $43M; net income drops 47% to $11M","bullets":["Revenue $43M, -9% YoY; net income $11M, -47% YoY; diluted EPS $0.11, -48% YoY.","EBITDA $18M, -26% YoY; net income margin 26% (down 19pp); EBITDA margin 43% (down 10pp).","CEO attributes revenue decline to April 2025 franchise fee restructuring; core business fundamentals remain solid.","Franchise locations rose 33 to 284; LTM customers up 10% to 6.76M; repeat rate 72%."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-222720","json":"https://secwatch.observer/filing/0001193125-26-222720.json","markdown":"https://secwatch.observer/filing/0001193125-26-222720.md","text":"https://secwatch.observer/filing/0001193125-26-222720.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1930313/000119312526222720/0001193125-26-222720-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1930313/000119312526222720/sbc-20260514.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-14T10:55:09.043695+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"fab3c6d23c22b5d85f1f63f6d72be5f5c51f7b22","claim":"SBC Medical Group Holdings Inc reported the three months ended March 31, 2026 results: revenue $43 million, net income $11 million, EPS $0.11.","evidence_excerpt":"across a wide range of healthcare fields, today announced its financial results for the three months ended March 31, 2026. First Quarter 2026 Highlights • Total revenues were $43 million, representing a 9% year-over-year decrease. • Net income attributable to SBC Medical Group Holdings Incorporated was $11 million, representing a 47% year-over-year decrease. Net","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1930313/000119312526222720/0001193125-26-222720-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the three months ended March 31, 2026"},{"label":"Revenue","value":"$43 million"},{"label":"Net income","value":"$11 million"},{"label":"EPS","value":"$0.11"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}